Aquilo Partners is a distinguished life sciences investment bank based in Wellesley, MA, specializing in mergers and acquisitions, licensing partnership transactions, and private placements. With a senior team of experienced bankers dedicated to a transparent and thoughtful approach, Aquilo has advised on over $15 billion in M&A and partnering transactions, raising more than $8 billion in capital.
The company's proven track record includes facilitating significant transactions in the life science industry, such as the acquisition of Xlumena by Boston Scientific and strategic partnerships with leading pharmaceutical companies like AbbVie, Sanofi, and AstraZeneca. Aquilo Partners' expertise spans across biotechnology, big pharma, specialty pharma, medical devices, research tools, and diagnostics, maintaining top-tier relationships globally within the life science sector.
Generated from the website